Happy New Year!

Anyfusion Cylinder pump, Drug Library cylinder pump, TCI cylinder pump

Anyfusion clean bench type ACPi system.

With you, 2022 was recognized by the FDA, the world's top medical institution, to achieve the purpose and goal of establishing the first mover industrial model as a next-generation innovative product leading the medical advanced markets such as the U.S., Japan, and Germany.

(NICU) Of the 170 million newborns born annually, about 29 million, or 17 percent, are premature and underweight. Very small amounts of medicines and nutritional supplements must be quantified and accurately injected in real-time to grow and develop into normal babies. Unfortunately, the injection pump that has been used so far has not functioned properly, so many children have had to live with sadness by changing their fate or enduring pain with their families in a healthy and unhappy life.

(ICU) Drug library pumps are equipped with drug properties, or Pharmacokinetics, to increase drug injection accuracy, and more than 25 million won per unit and expensive dedicated sets are leading the developed market. Unfortunately, Korea has no cars because it is expensive.

(Operating Room) Anesthesia is a medical accident caused by overreaction and incorrect administration of excess or low doses, which is quite dangerous, and real-time accurate and precise injection according to the patient's medical and clinical grounds requires high concentration. The target control injector (TCI) pump, which is used for injection in many hospitals around the world by programming the characteristics of anesthetic drugs and clinical factors of patients, is more than 25 million won per unit, and the exclusive consumables are also expensive. Unfortunately, we are mainly using it only in large hospitals due to cost issues.

All of these pumps are inaccurate and unstable due to the limitations of the original technology with peristaltic infusion pump and syringe pump technology, and due to structural problems such as separate use depending on function and purpose, clinical and medical target quantification, accuracy, and precision injection are not possible. Due to the problem of hospital balance, which cannot be depreciated until equipment prices are replaced with three equipment with performance fees, patients and medical staff who use the world's lowest model pump are enduring labor. For more than 70 years, the FDA has also set up a separate department for special management due to this problem. These are the pumps that the FDA compared to the Anyfusion cylinder pump at STeP. Anyfusion source technology has identified it as a technology that overcame it as the safety and oil did not improve due to the limitations of the original technology even if a program that increased safety and oil was built in. It is only a matter of time before the paradigm of the market changes.

Many advanced countries used drug library pumps because the safety and effectiveness of patients are the top priority despite expensive equipment, exclusive consumables, and high wages. However, in Korea, the use of expensive equipment cannot be used due to the deterioration of the hospital balance due to the inability to calculate consumables and low fees for performance fees). Unfortunately, many countries like us cannot use the world's cheapest and lowest-spec pumps unless they are backed by the system and government support, forcing governments to use more unsafe and ineffective dangerous equipment. It's our chance.

As unsafe equipment is used, it is exposed to safety and effectiveness risks, and medical accidents are bound to occur, so patients and their families must lose their lives and health and carry the misfortune and pain. In order to overcome technical problems without supporting the system, it has been replaced by the efforts and work of medical staff with minimal clinical and medical effects. As such, excessive work, development into secondary diseases, and prolonged hospitalization period were the main causes of the increase in medical expenses. (Long-cherished desire in the medical community)

Drug library pump and TCI pump are high-end technologies of existing drug injection pumps and are sold at high prices. Although it has some effects, these programmed built-in pumps cannot be improved, as the FDA pointed out, because the pump itself has fundamental safety and oil problems. It continued to recommend the development of products to solve safety and oil, but no one could, and the FDA recognized and selected it as an alternative to Anyfusion solving the problem. There will be a big wave soon.

The world's most unsafe and ineffective medical device is Anyfusion, the world's safest and most effective medical device, and there is no choice in advanced countries such as the United States, where patient-centered and medical cost reduction are on the ground. Regardless of the price of reasonable equipment and consumables that can be accommodated regardless of large, medium, and small hospitals, perfect accuracy, infection prevention, syringe-less, airless, workload-less, death volume-less, inadvertent, accident bolus-less, etc.(7-less), is a dream of a new year's medical pump.

It should be considered like the FDA so that patients and medical staff can quickly apply medical devices and medicines whose stability and effectiveness are vital, and the Ministry of Food and Drug Safety and the Ministry of Health and Welfare (CIA) are delayed due to any regulations or system, putting many patients at risk of medical accidents. FDA guarantees stability and effectiveness and should take precedence over everything. This is why FDA, UL (Emergo), Company L, medical device partners in the United States and around the world, hospitals, and patients need Anyfusion, and why competent and large partners come forward.

Anyfusion ACPi System, an integrated system from anticancer (injection) preparation to injection, is an innovative technology that ensures the safety of preparers and patients and prevents the risk of medical accidents. In addition, it is in the spotlight as a general-purpose sterile preparation equipment around the world due to its high cost-effectiveness and wide range of preparations with reasonable equipment prices and consumables that can be accommodated by all medical institutions. Anyfusion ACPi system is an innovative technology recognized by the FDA and the Ministry of Food and Drug Safety, and although the world is 100% syringes, some are dispensing robots, most of them will be replaced, and dispensing robots will be useless. The Anyfusion ACPi system is a multifunctional equipment that includes TPN preparation, PCA ballon filling, reconstruction, fluid ballroom adjustment, and injection in addition to anti-cancer (injection) preparation. It also improves the environment by not using syringes. (ESG)

We will increase reliability and brand value in the global market with Anyfusion cylinder pump and expand the market with Anyfusion ACPi system. Development of a clean bench type Anyfusion ACPi system that ensures safety and a cartridge for preparation with a high preparation speed are intended to lead the sterile preparation market around the world, including Korea. It is a representative medical device of Meinntech Co., Ltd. that quickly completes FDA, CE, PMDA, and KFDA certification and approval, and will become Korea's representative First Mover paradigm company.

Twenty-one years ago, due to high labor costs and growth in emerging industrial countries such as China and India, the Fast follow model decided to become less competitive and established Meinntech under the banner of Medical Innovation Technology. All systems and policies cannot escape the fast follow model, but it is too hard and difficult to challenge with first mover consciousness and thinking. Everything is impossible. I have been able to overcome the adversity based on the contribution and cooperation of shareholders, so I have been working hard without losing hope. Thank you. I'll repay you. With the goal of leading the global market with the first mover product, the company developed EZ Regular and Anyfusion, which will bring attention to the world and revolution in the medical world, and became the first FDA innovative medical device in Korea to achieve its goal of being selected as the world's first STeP. The policies and systems of the Ministry of Food and Drug Safety, the Ministry of Health and Welfare (HEALTH INSURANCE REVIEW & ASSESSMENT SERVICE), and the Category Department's periodic medical device business group are still at the fast follow level, but they have joined the change and innovation with Anyfusion.

Since the establishment of the government in 2020, the Ministry of Science and ICT, the Ministry of Trade, Industry and Energy, the Ministry of Health and Welfare, and the Ministry of Food and Drug Safety have launched a pan-ministerial medical device project to support R&D. Anyfusion, the first mover, was eliminated from the project group's support project, the Ministry of Food and Drug Safety's designation of innovative medical devices in 2021, and the Ministry of Health and Welfare's designation of innovative medical devices. All medical devices selected for these projects and institutions are fast follow technology at the level of modify and copy. The project group, the Ministry of Food and Drug Safety, and the Ministry of Health and Welfare all agreed that although they have invested hundreds of trillion won during various governments to seek a transition, the transition to first mover is a long way off, and innovative technologies like Anyfusion are impossible in the future. In the same vein, the lack of core source technology to lead the global market regardless of government departments is a waste of huge taxpayers' money.

Ironically,

(1) In July 2017, KISTI reported that Anyfusion is an innovative technology that will change the world's drug injection pump market.

(2) We failed the document screening in the Ministry of SMEs and Startups' BIG 3 task, which only venture companies with less than 7 years of experience, but we cannot understand that the original technology that will lead the world market is not qualified, so we immediately call the person in charge and pass the document in one day. With the government support project, we developed the world's first general-purpose HIS linked anticancer (injection) preparation system and are becoming necessary equipment around the world.

(3) Due to the export voucher support project regulations organized by the Ministry of SMEs and Startups, we have not received support for consulting costs related to FDA STeP designation. However, our Anyfusion was classified as the first FDA innovative medical device in Korea and was selected as the world's first FDA STeP. Through these facts, we learned that the United States supported and selected technology-oriented support for the development of the medical industry, not for conditions, and that truth and justice were alive. It will now lead quickly to results. It gives you hope and courage. It is an unfortunate reality that medical-related ministries are too late for fair. So it was harder and harder.

In addition, the FDA reviewer (judge) recommended STeP for innovation in safety and effectiveness during the 510(K) certification pre-submission data review. Regardless of high professionalism, perspective, non-English speaking, and post-American interests, we respect the selection of direct screening for 60 days, including daily, patients, medical staff and the state. It looks like an advanced country. It's time to show everything as a result. In 2023, it is time to bloom what you have prepared with passion and effort without giving up as above. We will plan to lead the global market with our partners and work together to repay them with fruit step by step.

With IPO in 2024, 1 trillion won in 2027, 2 trillion won in 2030, and sales of more than 10 trillion won for the first time in the pharmaceutical, bio, and medical device industries, our goal is to become the world's top 10 medical device companies, and we will bless everyone involved by increasing the company's value with high profitability.

Thank you.